EGFR Mutated Non-small Cell Lung Cancer Patients
Oncology·MeSH: Lung Neoplasms
Prevalence
75.0 / 100K
Incidence
47.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target EGFR Mutated Non-small Cell Lung Cancer Patients?
There are 1 clinical trial targeting EGFR Mutated Non-small Cell Lung Cancer Patients tracked by BioSniper.
What is the prevalence of EGFR Mutated Non-small Cell Lung Cancer Patients?
The estimated prevalence of EGFR Mutated Non-small Cell Lung Cancer Patients is approximately 75.0 per 100,000 population.
Deep-dive into EGFR Mutated Non-small Cell Lung Cancer Patients
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis